HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study.

Abstract
The sarcoglycan subcomplex (SGC) is a well-known system of interaction between extracellular matrix and sarcolemma-associated cytoskeleton in skeletal and cardiac muscle. The SGC is included in the DGC made up of sarcoplasmic subcomplex and a dystroglycan subcomplex. Recent developments in molecular genetics have demonstrated that the mutation of each single sarcoglycan gene, causes a series of recessive autosomal muscular dystrophies, dystrophin-positive, called sarcoglycanopathies or limb girdle muscular dystrophies. Our recent studies have demonstrated that costameres are a proteic machinery made up of DGC and vinculin-talin-integrin system, also revealing the colocalization of sarcoglycans and integrins in adult human skeletal muscle. These results may support the hypothesis of the existence of a bidirectional signalling between sarcoglycans and integrins in cultured L6 myocytes. The hypothesis of bidirectional signalling between sarcoglycans and integrins could be supported by the identification of a skeletal and cardiac muscle filamin2 as a gamma-sarcoglycan, delta-sarcoglycan and, hypothetically, beta1 integrin interacting protein. Our results, acquired with an immunofluorescence study on adult human skeletal muscle affected by LGMD type 2D and 2C, showed that in LGMD2D: a) alpha-sarcoglycan staining is severely reduced; b) the beta-gamma-delta-sarcoglycan subunit and all tested integrins staining are clearly detectable; c) filamin2 is normal and shows a costameric distribution. In LGMD2C: a) alpha-sarcoglycan staining is preserved; b) the beta-gamma-delta-sarcoglycan subunit staining is severely reduced; c) the alpha7B-integrin is slightly reduced and beta1D-integrin is severely reduced; d) filamin2 is severely reduced. Other tested proteins of the two systems show a normal staining pattern in both sarcoglycanopathies. Our study seems to confirm, for the first time on adult human skeletal muscle of subjects affected by LGMDs, the hypo-theses of: a) the existence, in mouse myotubes in culture, of two distinct subunits in sarcoglycans subcomplex; b) the presence of a bidirectional signalling between sarcoglycans and integrins, previously demonstrated on rat cultured L6 myocytes; c) the interaction of FLN2 with both sarcoglycans and integrins. These results may stimulate the search of yet unidentified common interactors of both fiber-extracellular matrix interaction systems.
AuthorsGiuseppe Anastasi, Giuseppina Cutroneo, Fabio Trimarchi, Giuseppe Santoro, Daniele Bruschetta, Placido Bramanti, Antonina Pisani, Angelo Favaloro
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 14 Issue 6 Pg. 989-99 (Dec 2004) ISSN: 1107-3756 [Print] Greece
PMID15547664 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Contractile Proteins
  • FLNC protein, human
  • Filamins
  • Integrins
  • Microfilament Proteins
  • Protein Subunits
  • Sarcoglycans
  • Talin
  • Vinculin
Topics
  • Biopsy
  • Contractile Proteins (metabolism)
  • Filamins
  • Humans
  • Immunohistochemistry
  • Integrins (metabolism)
  • Microfilament Proteins (metabolism)
  • Microscopy, Confocal
  • Muscle, Skeletal (metabolism, pathology)
  • Muscular Dystrophies, Limb-Girdle (metabolism, pathology)
  • Protein Subunits (metabolism)
  • Sarcoglycans (metabolism)
  • Talin (metabolism)
  • Vinculin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: